Statin Discontinuation and Life-Limiting Illness in Non-Skilled Stay Nursing Homes at Admission.
Deborah S MackJonggyu BaekJennifer TjiaKate L LapanePublished in: Journal of the American Geriatrics Society (2020)
Statin use continues in a large proportion of Medicare beneficiaries after admission to a nursing home. Additional deprescribing research, which identifies how to engage nursing home residents and healthcare providers in a process to safely and effectively discontinue medications with questionable benefits, is warranted.